RFFC:ARCA-RiverFront Dynamic US Flex-Cap

ETF | Others | NYSE Arca

Last Closing

USD 32.25

Change

+0.27 (+0.84)%

Market Cap

USD 6.73M

Volume

0.04M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

The investment seeks to provide capital appreciation. The fund invests at least 65% of its net assets in a portfolio of equity securities of publicly traded U.S. companies. Equity securities include common stocks and common or preferred shares of real estate investment trusts. The fund may invest in small-, mid- and large-capitalization companies. It is non-diversified.

Inception Date: 06/06/2016

Primary Benchmark: S&P 1500 TR

Primary Index: S&P 500 TR USD

Gross Expense Ratio: NA%

Management Expense Ratio: 0.52 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Symbol Company Name Allocation
SCPS Scopus Biopharma Inc 2.64 %
EMMA Emmaus Life Sciences Inc 2.14 %
Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2019-08-21 )

Largest Industry Peers for Others

Symbol Name Mer Price(Change) Market Cap
SOJE SOJE 0.00 %

+0.70 (+3.66%)

USD 65.72B
JEPI JPMorgan Equity Premium Income.. 0.00 %

+0.44 (+0.79%)

USD 32.43B
DTB DTB 0.00 %

+1.19 (+6.19%)

USD 26.58B
DFAC Dimensional U.S. Core Equity 2.. 0.00 %

+0.36 (+1.19%)

USD 26.00B
GBTC Grayscale Bitcoin Trust (BTC) 0.00 %

-0.05 (-0.08%)

USD 23.75B
JPST JPMorgan Ultra-Short Income ET.. 0.00 %

+0.02 (+0.04%)

USD 22.73B
SGOV iShares® 0-3 Month Treasury B.. 0.00 %

+0.01 (+0.01%)

USD 19.79B
AVUV Avantis® U.S. Small Cap Value.. 0.00 %

+1.53 (+1.72%)

USD 10.49B
DFUV Dimensional US Marketwide Valu.. 0.00 %

+0.37 (+0.94%)

USD 10.15B
DFAT Dimensional U.S. Targeted Valu.. 0.00 %

+0.59 (+1.15%)

USD 9.40B

ETFs Containing RFFC

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 11.13% 61% D- 55% F
Dividend Return 0.80% 31% F 20% F
Total Return 11.93% 59% D- 52% F
Trailing 12 Months  
Capital Gain -9.90% 26% F 38% F
Dividend Return 1.28% 33% F 23% F
Total Return -8.62% 25% F 36% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A F
Dividend Return N/A N/A N/A N/A F
Total Return N/A N/A N/A N/A F
Average Annual (5 Year Horizon)  
Capital Gain 6.77% 80% B- 72% C
Dividend Return 7.57% 75% C 65% D
Total Return 0.80% 26% F 18% F
Risk Return Profile  
Volatility (Standard Deviation) 10.15% 53% F 71% C-
Risk Adjusted Return 74.61% 76% C+ 78% C+
Market Capitalization 6.73M 55% F 45% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.